Search results

  • CSV Spreadsheet
  • RSS Feed
(1 - 20 of 21)
Artificial immune cell, AI-cell, a new tool to predict interferon production by peripheral blood monocytes in response to nucleic acid nanoparticles
Biomotors, viral assembly, and RNA nanobiotechnology : current achievements and future directions
Biomotors, viral assembly, and rna nanobiotechnology: current achievements and future directions
Break to build : isothermal assembly of nucleic acid nanoparticles (NANPs) via enzymatic degradation
Broccoli fluorets : split aptamers as a user-friendly fluorescent toolkit for dynamic RNA nanotechnology
Change in lipofectamine carrier as a tool to fine-tune immunostimulation of nucleic acid nanoparticles
DNA-templated fluorescent silver nanoclusters inhibit bacterial growth while being non-toxic to mammalian cells
Demonstrating the synthesis and antibacterial properties of nanostructured silver
Editorial for the special issue on nucleic acid architectures for therapeutics, diagnostics, devices and materials
Expanding structural space for immunomodulatory nucleic acid nanoparticles (NANPs) via spatial arrangement of their therapeutic moieties
First step towards larger DNA-based assemblies of fluorescent silver nanoclusters: template design and detailed characterization of optical properties
Functionally-interdependent shape-switching nanoparticles with controllable properties
Functionally-interdependent shape-switching nanoparticles with controllable properties
Induction of cytokines by nucleic acid nanoparticles (NANPs) depends on the type of delivery carrier
Smart-responsive nucleic acid nanoparticles (NANPs) with the potential to modulate immune behavior
Special issue nanotechnology to overcome the world's most critical health issues: liposomes and beyond-a themed issue dedicated to Professor Yechezkel Barenholz
Structure and composition define immunorecognition of nucleic acid nanoparticles
The immunorecognition, subcellular compartmentalization, and physicochemical properties of nucleic acid nanoparticles can be controlled by composition modification
The recognition of and reactions to nucleic acid nanoparticles by human immune cells
Therapeutic immunomodulation by rationally designed nucleic acids and nucleic acid nanoparticles